Muscarinic M1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria

European Journal of Pharmacology

Volumn 346, Issue 2-3, 1998, Pages 227-236

  Islam, Md Amirul ^a   Nojima, Hiroshi ^a   Kimura, Ikuko ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acetylcholine; Atrium, right (Mouse); Muscarinic M1 receptor; V(max)

Indexed keywords

ACETYLCHOLINE; MUSCARINIC M1 RECEPTOR; OTENZEPAD; PIRENZEPINE; RABEPRAZOLE; RESERPINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE;

ACETYLCHOLINE RELEASE; ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; FACILITATION; HEART AUTOMATICITY; HEART FUNCTION; HEART REPOLARIZATION; HEART RIGHT ATRIUM; HEART STROKE VOLUME; INOTROPISM; ION TRANSPORT; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ANIMAL; CELL MEMBRANE POTENTIAL; HEART; HEART ATRIUM; HEART RATE; IN VITRO STUDY; KINETICS; MALE; MICROELECTRODE; PHYSIOLOGY;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; HEART; HEART ATRIA; HEART RATE; KINETICS; MALE; MEMBRANE POTENTIALS; MICE; MICROELECTRODES; MUSCARINIC AGONISTS; OXOTREMORINE; PARASYMPATHOLYTICS; PIRENZEPINE; RECEPTORS, MUSCARINIC;

EID: 0032502363     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00055-7     Document Type: Article

References (34)

1. Costa M., Majewski H. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br. J. Pharmacol. 102:1991;855-860.
2. Dörje F., Friebe T., Tacke R., Mutschler E., Lambrecht G. Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;284-289.
3. Du X.Y., Schoemaker R.G., Bos E., Saxena P.R. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. Eur. J. Pharmacol. 284:1995;119-127.
4. Eglen R.M., Watson N. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78:1996;59-68.
5. 2 receptors mediating opposite effects on neurotransmission in rabbit vas-deferens. Eur. J. Pharmacol. 151:1988;205-221.
6. Emala C.W., Aryana A., Levine M.A., Yasuda R.P., Satkus S.A., Wolfe B.B., Hirshman C.A. Basenji-greyhound dog: increased m2 muscarinic receptor expression in trachealis muscle. Am. J. Physiol. 268:1995;L935-L940.
7. Endoh M., Maruyama M., Iijima T. Attenuation of muscarinic cholinergic inhibition by islet activating protein. Am. J. Physiol. 249:1985;H309-H320.
8. 2 muscarinic receptor binding sites in the murine cerebral cortex and heart. J. Pharmacol. Exp. Ther. 235:1985;612-618.
9. Freeman S.E. Cholinergic mechanism in heart: interactions with 4-aminopyridine. J. Pharmacol. Exp. Ther. 210:1979;7-14.
10. 1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes. J. Physiol. 471:1993;41-60.
11. 2 receptor antagonist. Life Sci. 38:1986;1663-1672.
12. Goldberg N.D., Haddox M.K. Cyclic GMP metabolism and involvement in biological regulation. Annu. Rev. Biochem. 46:1977;823-896.
13. Grant A.O., Starmer C.F., Struss H.C. Antiarrhythmic drug action. Blockade of the inward sodium current. Circ. Res. 55:1984;427-439.
14. 2 subtypes in the human eye: QNB, pirenzepine, oxotremorine, and AF-DX 116 in vitro autoradiography. Br. J. Ophthalmol. 78:1994;555-559.
15. 2. Biochemical and functional characterization. Life Sci. 31:1982;2991-2998.
16. Hammer R., Berrie C.P., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
17. Hosey M.M. Diversity of structure, signalling and regulation with the family of muscarinic cholinergic receptors. FASEB J. 6:1992;845-852.
18. 1 muscarinic receptors. Mol. Pharmacol. 38:1990;895-905.
19. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
20. Jakob H., Oelert H., Rupp J., Nawrath H. Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle. Br. J. Pharmacol. 97:1989;1199-1208.
21. Katz, A.M., 1992. The arrhythmias: III. Premature systoles, tachycardias, flutter, and fibrillation. In: Katz, A.M. (Ed.), Physiology of the Heart, Raven Press, New York, pp. 569-608.
22. Kubo T., Maeda A., Sugimoto K., Akiba I., Mikami A., Takahashi T., Haga H., Haga T., Ichiyama A., Kanagawa K., Matsuo H., Mishina M., Hirose T., Numa S. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett. 209:1986;367-372.
23. + channel in isolated feline atrial and ventricular myocytes. J. Membr. Biol. 145:1995;143-150.
24. 2 muscarinic receptors. Mol. Pharmacol. 39:1991;359-363.
25. Pappano A.J. Vagal stimulation of the heartbeat: muscarinic receptor hypothesis. J. Cardiovasc. Electrophysiol. 2:1991;262-273.
26. Pappano A.J., Rembish R.A. Negative chronotropic effect of McN-A-343 and nicotine in isolated guinea-pig atria: insensitivity to blockade by tetrodotoxin. J. Pharmacol. Exp. Ther. 177:1971;40-47.
27. Rosen M.R., Steinberg S.F., Danilo P. Developmental changes in the muscarinic stimulation of canine Purkinje fibers. J. Pharmacol. Exp. Ther. 254:1990;356-361.
28. Schimerlik M.I. Structure and regulation of muscarinic receptors. Annu. Rev. Physiol. 51:1989;217-227.
29. 1 Muscarinic acetylcholine receptors in rat ventricular myocytes. Circ. Res. 79:1996;86-93.
30. Na in cardiac Purkinje fibres. Circ. Res. 63:1988;386-398.
31. Sjöstrand N.O., Swedin G. Effects of reserpine on the noradrenaline content of the vas deferens and the seminal vesicle compared with the submaxillary gland and the heart of rat. Acta. Physiol. Scand. 72:1968;370-377.
32. 3H]acetylcholine in the major pelvic ganglion of the rat. Am. J. Physiol. 264:1993;R1084-1088.
33. Sun L.S., Huber F., Robinson R.B., Bilezikian J.P., Steinberg S.F., Vulliemoz Y. Muscarinic receptor heterogeneity in neonatal rat ventricular myocytes in culture. J. Cardiovasc. Pharmacol. 27:1996;455-461.
34. Sun L.S., Vulliemoz Y., Huber F., Bilezikian, Robinson R.B. An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation. J. Mol. Cell. Cardiol. 26:1994;779-787.